Skip to content

Efficacy of 20 mg. VS 40 mg. Triamcinolone acetonide acetate under ultrasound guided caudal epidural steroid injection in patient with sciatica pain : Double-blinded randomized controlled trial study

Efficacy of 20 mg. VS 40 mg. Triamcinolone acetonide acetate under ultrasound guided caudal epidural steroid injection in patient with sciatica pain : Double-blinded randomized controlled trial study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20150329001
Enrollment
Unknown
Registered
2015-03-29
Start date
2014-07-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sciatica Sciatica EDSI epidural steroid injection triamcinolone acetonide acetate

Interventions

Comparison efficacy of 20 mg. and 40 mg. Triamcinolone acetonide acetate (TA) under ultrasound guided caudal epidural steroid injection (EDSI) in patient with sciatica pain in pain reduction by visual
Experimental Drug
Triamcinolone acetonide acetate

Sponsors

Orthopaedics department, Faculty of Medicine, Chiang Mai University
Lead Sponsor
Faculty of Medicine&#44
Collaborator
Chiang Mai University
Collaborator

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age 45 - 80 2.Nerve root compression at L3 - S1 that confirmed with lumbar MRI. 3.Failed conservative treatment at least 3 months.

Exclusion criteria

Exclusion criteria: 1.Patient had any history of steroid injection into epidural space. 2.Patient had a history of lumbosacral spinal surgery. 3.Patient had a history of triamcinolone acetonide acetate and lidocaine allergy. 4.Patient had an indication for surgery. 5.Patient had a history of bleeding tendency. 6.Patient had anticoagulant or anti platelet drugs. 7.Severe hypertension 8.Uncontrolled diabetic 9.Pregnancy 10. Immunocompromised patient 11.Skin compromized

Design outcomes

Primary

MeasureTime frame
Pain at 12 weeks after end of the intervention Visual analog scale

Secondary

MeasureTime frame
Disability score for back pain at 12 weeks after end of the intervention Roland - Morris Questionnaire Score

Countries

Thailand

Contacts

Public ContactTaninnit Leerapun

Orthopaedics department, Faculty of Medicine, Chiang Mai University

tleerapun@gmail.com053945544

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026